Verne Bio provides rapid on-site and mail-in genetic and pathogen testing kits for cannabis and hemp cultivation, enabling farmers to identify and manage plant health issues effectively. By utilizing advanced analytics, the company enhances crop productivity and reduces risks, ultimately improving the financial outcomes for growers of all sizes.
Funding
Funding not disclosed
Founders
Product
Problem
Cannabis and hemp cultivators face significant challenges in maintaining plant health due to pathogens and genetic variations, which can lead to reduced yields and financial losses. Traditional testing methods can be slow, costly, and require sending samples to off-site labs, delaying critical interventions.
Solution
Verne Bio offers rapid, on-site (i-Test) and mail-in (We-Test) diagnostic testing kits that enable cannabis and hemp cultivators to quickly identify and manage plant health issues. These tests detect pathogens, assess genetic traits such as gender, and quantify cannabinoid levels like THCa. By providing growers with timely insights into plant health, Verne Bio's testing solutions facilitate proactive interventions, optimize growing conditions, and minimize crop losses. The company also provides consulting services in biotechnology, pharmaceutical research and development, and genetic science.
Target Audience
Verne Bio serves cannabis and hemp cultivators of all sizes, from small farms to large commercial operations, who seek to improve crop yields and manage plant health risks.
Features
- i-Test: Rapid, on-site testing kits for immediate analysis of plant health.
- We-Test: Mail-in testing service for comprehensive lab analysis.
- Pathogen detection: Identification of common cannabis and hemp pathogens.
- Genetic testing: Determination of plant gender and other genetic traits.
- Cannabinoid quantification: Measurement of THCa and other cannabinoid levels.
- Full panel pathogen testing.
- Consulting services in biotechnology, pharmaceutical research and development, and genetic science.